Continue to Site

Carl Zeiss Meditec revenue up nearly 10% in Q1

February 11, 2019 By Chris Newmarker

Carl Zeiss Meditec officials are boasting a strong start to their present fiscal year, announcing that revenue increased to €323.6 million ($382.4 million) during the company’s first quarter.

Revenue for the quarter ended Dec. 31 was up 9.8% year over year. Earnings before interest and taxes also increased, up 23.7% to €48.1 million ($56.4 million).

The company’s ophthalmic devices business saw its revenue increase by 10.7%, to €239.5 million ($283 million), driven by laser vision correction systems and devices and consumables in cataract surgery. The microsurgery business’s revenue was up 7.4%, to €84.2 million ($99.5 million), with strong sales of neurosurgical visualization systems for the treatment of tumors and vascular disease.

“We have made a successful start to the new financial year and were able to further expand our market share in both strategic business units,” said Ludwin Monz, president and CEO of Carl Zeiss Meditec AG.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.